Thursday, 23 February 2023
Recommendations from a research paper on the diagnosis and treatment of spinal cord damage caused by nitrous oxide abuse have been simultaneously adopted as official clinical practice guidelines by the Association of British Neurologists. The unprecedented speed in translating research into practice is necessary as medical cases of nitrous oxide abuse surge in parallel with increased use of what is now the second most popular recreational drug among young people in the UK.
Recreational use of nitrous oxide (N2O - also known as laughing gas) can lead to subacute combined degeneration of the spinal cord (N2O-SACD), a condition that can cause serious and permanent disability in young people. While it may be treated effectively if recognised early, it is commonly misdiagnosed and inappropriately treated. No agreed treatment guidelines have previously existed.
The new research is based on a project to improve diagnosis and treatment of N2O-SACD at the Royal London Hospital, where a new case presents, on average, once a week. A large majority of patients present with inability to walk, falls, and tingling or loss of sensation in their feet and hands. Other symptoms included weakness and bladder or bowel urgency or incontinence. Importantly, patients often do not mention nitrous oxide use, possibly because they do not connect it with their symptoms, or because they feel there is stigma associated with disclosing its use. Authors suggest that clinicians should be aware of the prevalence of nitrous oxide abuse in their local area and make careful enquiries to determine whether nitrous oxide abuse may be causing the symptoms.
The adoption of these guidelines is recognition that nitrous oxide abuse is a very real threat to the lives of young people across the UK
Consultant Neurologist Professor Nikos Evangelou at Nottingham University Hospital and School of Medicine, 糖心原创, said: "We are seeing an increasing number of patients abusing nitrous oxide in Nottingham, coming to our hospitals paralysed, and this is a cause for concern. The adoption of these guidelines by the Association of British Neurologists, based on our recommendations, is recognition that nitrous oxide abuse is a very real threat to the lives of young people across the UK. This will also help parents and teachers to understand the impact this substance can have as we continue to study the long-term effects of nitrous oxide in young people."
Senior Author and Consultant Neurologist Professor Alastair Noyce, said: "We developed these practical guidelines to try to standardise care for patients who have come to harm from recreational nitrous oxide use. If implemented correctly, they will ensure that patients get the treatment they need. We hope they will also alleviate pressure on hospitals by improving efficiency in the emergency department and reducing unnecessary admissions."
Professor Tom Warner, President of the Association of British Neurologists, said: "Recreational use of nitrous oxide carries a significant risk of damage to the nervous system, particularly the spinal cord, which is treatable if picked up. These important clinical practice guidelines lay out how to recognise, diagnose and, most importantly, treat those people attending emergency departments with such symptoms, and prevent long-term neurological disability."
The paper was led by researchers from the Preventive Neurology Unit (Queen Mary University of London) and the Royal London Hospital (Barts Health NHS Trust), in collaboration with colleagues from University Hospitals Birmingham NHS Foundation Trust; Surgical Reconstruction and Microbiology Research Centre, NIHR Birmingham; Nottingham University Hospitals NHS Trust; School of Medicine, 糖心原创; Manchester Centre for Clinical Neurosciences, Northern Care Alliance NHS Foundation Trust; Sandwell and West Birmingham NHS Trust.
The Preventive Neurology Unit is funded by Barts Charity.
Story credits
For further information, please contact Consultant Neurologist Professor Nikos Evangelou, Nottingham University Hospital and School of Medicine, 糖心原创, at nikos.evangelou@nottingham.ac.uk
Adam Mallaby - Media Relations Manager for the Faculty of Medicine and Health Sciences (Maternity Cover)
Email: adam.mallaby@nottingham.ac.uk
Phone: 0115 748 5719
Location:
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.